Skip to main content
Fig. 3 | BMC Urology

Fig. 3

From: Post-ESWL urinary osteopontin level and ion-activity product of calcium oxalate are associated with stone recurrence after 5-year follow-up

Fig. 3

Changes in urinary expression of chemokine and matrix proteins. (a) Urinary CXCR4 (40 kDa) levels were significantly higher in stone patients before ESWL compared to controls. Following ESWL, CXCR4 levels significantly increased compared to pre-ESWL levels in stone patients and dropped below pre-ESWL level at 4 week (b) MMP2 (Matrix Metalloproteinases 2, 72 kDa) showed no significant different in stone patients before ESWL compared to controls. MMP2 elevated significantly at 2 weeks following ESWL and returned to control level at four weeks. (c) MMP9 (Matrix Metalloproteinases 9, 92 kDa) showed no significant different in stone patients before ESWL compared to controls. MMP2 elevated significantly at 2 weeks following ESWL and returned to control level at four weeks

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us